Nomori H, Horio H, Suemasu K
Department of Thoracic Surgery, Saiseikai Central Hospital, Tokyo, Japan.
Chest. 1999 Mar;115(3):874-80. doi: 10.1378/chest.115.3.874.
We developed anterior limited thoracotomy (ALT) with intrathoracic illumination for curative resection of lung cancer. The present study evaluated the benefits of ALT by retrospective comparison with anteroaxillary thoracotomy (AAT) and posterolateral thoracotomy (PLT).
Lung cancer patients, who underwent lobectomy via ALT (n = 28), AAT (n = 28), and PLT (n = 28), were matched by gender and age. Operating time, blood loss during operation, chest tube drainage volume 24 h after surgery, chest tube drainage duration, and vital capacity (VC) and chest pain from early to late postoperative period were studied for ALT, AAT, and PLT. Early postoperative chest pain was evaluated by a visual analog scale and analgesic requirements, and chronic pain was divided into five grades.
No difference was observed in operating time among ALT, AAT, and PLT. ALT has the following advantages over PLT: (1) less blood loss during surgery (p < 0.05); (2) reduced postoperative drainage volume (p < 0.05) resulting in shorter chest tube drainage (p < 0.001); (3) diminished impairment of VC for 1 week to 6 months after surgery (p < 0.01 or p < 0.001); and (4) reduced pain from 1 day and 6 months after surgery (p < 0.001). ALT also has the advantage over AAT in reduced pain 5 days (p < 0.01) and 7 days (p < 0.05) after surgery and in decreased analgesic requirements during 14 days after surgery (p < 0.05).
ALT is a sufficient and minimally invasive thoracotomy alternative to PLT or AAT for curative lung cancer resection.
我们开发了一种用于肺癌根治性切除的前路有限开胸术(ALT),并采用胸腔内照明技术。本研究通过与腋下开胸术(AAT)和后外侧开胸术(PLT)进行回顾性比较,评估了ALT的优势。
对通过ALT(n = 28)、AAT(n = 28)和PLT(n = 28)进行肺叶切除术的肺癌患者,按照性别和年龄进行匹配。研究了ALT、AAT和PLT的手术时间、术中失血量、术后24小时胸腔引流液量、胸腔引流持续时间以及术后早期至晚期的肺活量(VC)和胸痛情况。术后早期胸痛采用视觉模拟评分法进行评估,并记录镇痛需求,慢性疼痛分为五个等级。
ALT、AAT和PLT的手术时间无差异。与PLT相比,ALT具有以下优势:(1)术中失血量更少(p < 0.05);(2)术后引流量减少(p < 0.05),导致胸腔引流时间缩短(p < 0.001);(3)术后1周内至6个月肺活量的损害减轻(p < 0.01或p < 0.001);(4)术后1天至6个月疼痛减轻(p < 0.001)。与AAT相比,ALT在术后5天(p < 0.01)和7天(p < 0.05)疼痛减轻以及术后14天内镇痛需求减少(p < 0.05)方面也具有优势。
对于肺癌根治性切除,ALT是一种足够且微创的开胸术替代PLT或AAT的方法。